Home LiteratureArticle Details
PMID: 11191051 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Review

Tek/Tie2 signaling: new and old partners.

Cancer metastasis reviews ·Vol. 19 ·No. 1-2 ·2000-00-00 ·Pages 13-7

Jones N, Dumont DJ

Abstract

A common property amongst angiogenic ligands such as the vascular endothelial growth factors and the angiopoietins is that they can elicit multiple responses depending upon the context of their expression and the presence of other growth factors. Study of the signal transduction pathways initiated by these growth factors provides insight into the molecular and cellular mechanisms that regulate vessel assembly. Key components of signal transduction cascades can then be used as potential targets in angiogenic therapies. This commentary reviews the recent advances into understanding the molecular signaling pathways mediated through the angiopoietin receptor, Tek/Tie2, as well as their effect on the regulation of distinct cellular aspects of angiogenesis.

MeSH Terms
Animals Humans Models, Cardiovascular Neoplasm Proteins/physiology Neovascularization, Pathologic Neovascularization, Physiologic Proto-Oncogene Proteins Receptor Protein-Tyrosine Kinases/metabolism Receptor, TIE-2 Signal Transduction
Chemicals
MEN1 protein, human Neoplasm Proteins Proto-Oncogene Proteins Receptor Protein-Tyrosine Kinases Receptor, TIE-2
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Jones N
Division of Cancer Biology Research, Sunnybrook and Women's College Health Sciences Centre, Toronto, Ontario, Canada.
Dumont D J
Article Info
Journal
Cancer metastasis reviews
Abbr.
Cancer Metastasis Rev
ISSN
0167-7659
Published
2000-00-00
Pages
13-7
Language
English
Region
Netherlands
NLM ID
8605731
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]